Next Article in Journal
Four Weeks of Aerobic Training Affects Cardiac Tissue Matrix Metalloproteinase, Lactate Dehydrogenase and Malate Dehydrogenase Enzymes Activities, and Hepatorenal Biomarkers in Experimental Hyperhomocysteinemia in Rats
Next Article in Special Issue
In Search of Effective Anticancer Agents—Novel Sugar Esters Based on Polyhydroxyalkanoate Monomers
Previous Article in Journal
Redox Mechanism of Azathioprine and Its Interaction with DNA
Previous Article in Special Issue
Anticancer Activity of Two Novel Hydroxylated Biphenyl Compounds toward Malignant Melanoma Cells
 
 
Article
Peer-Review Record

Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell Lines

Int. J. Mol. Sci. 2021, 22(13), 6806; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22136806
by Pariyakorn Udomwan 1,2, Chamsai Pientong 1,2, Panwad Tongchai 1,2, Ati Burassakarn 1,2, Nuchsupha Sunthamala 2,3, Sittiruk Roytrakul 4, Supawadee Suebsasana 5 and Tipaya Ekalaksananan 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Int. J. Mol. Sci. 2021, 22(13), 6806; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22136806
Submission received: 1 June 2021 / Revised: 22 June 2021 / Accepted: 22 June 2021 / Published: 24 June 2021
(This article belongs to the Collection Anticancer Drug Discovery and Development)

Round 1

Reviewer 1 Report

The authors present the effects of Andrographolide on inducing apoptosis in HPV16-positive cervical cancer cells. The study first tested the cytotoxicity of andrographolide in cervical cancer cell lines SiHa, CaSki, and C33A and identified CC50 activities in <100 μM range using cell viability assay. Interestingly, Androg enhanced apoptotic cell 254 death in HPV16-positive cells, Androg specifically exhibited anti-HPV positive cervical 255 cancer activity through the mechanism of apoptosis. Mechanistically, based on the proteomic profiling, the anti-tumor activity of Androg essentially relied on the reduction of host cell proteins which are associated with ubiquitin-mediated proteolysis pathways, particularly HERC4 and SMURF2.

Overall, the experiments are rigorous, clearly presented, and compelling and represent an important contribution to the field.

The relatively minor points below should be addressed prior to publication.

Figure-1 represents the activity of three cell lines after 45 h treatment of Androg at different concentrations. Adding the time course experiment for (100uM) here will be useful to understand the potency of the Androg over time.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The authors validated the anti-HPV-associated cervical cancer activity of andrographolide natural product. They have showed the interference of the E6-mediated p53 degradation with the andrographolide promoting cancer cell death in HPV-induced malignant cells. The paper is clearly written and recommended to publish in Int. J. Mol. Sci. after the minor text corrections.

  1. I recommend the authors to use either andrographolide or Androg throughout the document for the consistency.
  2. Change the text in line 83 “the previous report by the current authors indicated….” to “in our previous work we indicated…..”
  3. Remove full stop after 48 h in line 140.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 3 Report

This is an interesting study about proteomics analysis of andrographolide-induced apoptosis via the regulation of tumor suppressor p53 proteolysis in cervical cancer-derived human papillomavirus 16-positive cell lines. The authors found that the restoration of p53 in HPV16-positive cervical cancer cells might be achieved by disruption of E3 ubiquitin ligase activity by Androg.

The paper is well written. Materials and methods are adequate. Results are well described with graphical summaries.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop